FDA Clearance Tracker · P860022-S054
BOSTON EQUEALENS RIGID GAS/II RIGID GAS PERMEABLE CONTACT LENS
Last checked: Nov 20, 2026Latest source record: May 6, 2002 (this decision)Source: openFDAMethods & limitations
Decided
May 6, 2002
Approved
Time to decision
96 days
Received Jan 30, 2002. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P860022-S054
- Device name
- BOSTON EQUEALENS RIGID GAS/II RIGID GAS PERMEABLE CONTACT LENS
- Applicant
- Bausch & Lomb
- Applicant location
- Rochester, NY
- Received
- Jan 30, 2002
- Decided
- May 6, 2002
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P860022
Device type
- Device class
- Class III
- Regulation
- 21 CFR 886.5916
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR AN ASPHERIC DESIGN FOR EXTENDED WEAR AND LABELING CHANGES FOR THE DEVICE. REQUESTED LABELING CHANGES INCLUDE: 1) CHANGE FROM THE TITLE "PATIENT INSTRUCTIONS" TO "PATIENT CARE GUIDE". 2) UPDATE THE PRESCRIPTION CAUTION STATEMENT. 3) MODIFY THE PRODUCT DESCRIPTION SECTION OF THE PACKAGE INSERT AND PROFESSIONAL FITTING AND INFORMATION GUIDE AS FOLLOWS: A) ADD THE DESCRIPTIONS FOR BOTH THE ASPHERIC DESIGN (EXTENDED AND DAILY WEAR) AND THE PREVIOUSLY APPROVED BIFOCAL LENS (DAILY WEAR ONLY) AND SPECIFY DAILY WEAR FOR THE TORIC AND BIFOCAL DESIGNS; B) REMOVE FROM THESE PRODUCT DESCRIPTION SECTIONS THE PHRASE "WITHOUT UV" BECAUSE THIS OPTION IS NO LONGER AVAILABLE; AND C) CHANGE THE COLOR NAME OF THE BLUE LENS MATERIAL FROM "DARK BLUE" TO "ELECTRIC BLUE". 4) CORRECT THE MANUFACTURER'S ADDRESS. 5) UPDATE THE WORDING OF THE UV WARNING AND CLARIFY THE EXTENDED WEAR INDICATION AS IN THE INDICATION STATED BELOW."THE BOSTON EQUALENS (ITAFLUOROFOCON A) RGP CONTACT LENS IS INDICATED FOR DAILY OR EXTENDED WEAR FROM 1 TO 7 DAYS BETWEEN REMOVALS FOR CLEANING AND DISINFECTION AS RECOMMENDED BY THE EYE CARE PRACTITIONER. THE LENS IS INDICATED FOR EXTENDED WEAR FOR THE CORRECTION OF REFRACTIVE AMETROPIA (MYOPIA AND HYPEROPIA) IN NOT-APHAKIC PERSONS WITH NON-DISEASED EYES IN POWERS FROM -20.00D TO +12.00D. THE LENS IS INDICATED FOR DAILY WEAR FOR THE CORRECTION OF REFRACTIVE AMETROPIA (MYOPIA, HYPEROPIA, ASTIGMATISM AND PRESBYOPIA) IN APHAKIC AND NOT-APHAKIC PERSONS WITH NON-DISEASED EYES. THE LENS MAY BE DISINFECTED USING A CHEMICAL DISINFECTION SYSTEM ONLY."
Source documents
Other decisions for Bausch & Lomb
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Bausch + Lomb Multifocal for Astigmatism (kalifilcon A) One-Day Soft (hydrophilic) Contact Lens510(k)
K262941 · Decided Oct 16, 2026 · 56 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.